Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

617
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
617

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Retraction Casts Doubt on Timing Effects of Immunotherapy.

Cancer discovery·2026
Same journal

mtDNA Lineage Tracing Reveals Monocyte Fate Bias Prior to Tumor Infiltration.

Cancer discovery·2026
Same journal

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Cancer discovery·2026
Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026
Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026
Same journal

Acquisition of Centromeric Features Supports Telomere Integrity.

Cancer discovery·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

NSCLC Evolution Studies Refine Biomarkers

    Cancer Discovery
    |November 7, 2019
    PubMed
    Summary
    This summary is machine-generated.

    TRACERx analyses reveal new biomarkers for non-small cell lung cancer (NSCLC) prognosis. These findings also identify T-cell receptors for developing novel adoptive cellular immunotherapies for NSCLC patients.

    More Related Videos

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.4K
    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    11.0K

    Related Experiment Videos

    Last Updated: Jan 4, 2026

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.6K
    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.4K
    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    11.0K

    Area of Science:

    • Oncology
    • Immunology
    • Genetics

    Background:

    • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide.
    • Understanding the genetic underpinnings of NSCLC is crucial for developing effective treatments.
    • Adoptive cellular immunotherapy holds promise for cancer treatment but requires identification of specific targets.

    Purpose of the Study:

    • To analyze the genetic landscape of NSCLC through the TRACERx initiative.
    • To identify novel prognostic biomarkers in NSCLC.
    • To discover T-cell receptors (TCRs) with potential therapeutic applications in NSCLC immunotherapy.

    Main Methods:

    • Utilized comprehensive genomic analyses from the TRACERx study cohort.
    • Performed correlative analyses to link genetic alterations with clinical outcomes.
    • Investigated T-cell receptor sequences and their association with tumor characteristics.

    Main Results:

    • Identified several new genetic biomarkers with potential prognostic value in NSCLC.
    • Discovered specific T-cell receptors that are frequently associated with NSCLC.
    • These findings provide insights into the tumor immune microenvironment of NSCLC.

    Conclusions:

    • The TRACERx study provides valuable data for understanding NSCLC genetics.
    • New biomarkers may improve patient stratification and treatment selection for NSCLC.
    • Identified TCRs represent promising targets for future NSCLC adoptive cellular immunotherapy development.